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Abstract
Addiction is a chronic and recurring disease that recurrence phenomenon is the most important challenge in treatment of this
disease. Recent experiences have shown that synthetic drugs have undesirable side effects. Recent studies on medicinal plants
have shown that they might be effective in treatment of different stages of addiction with lower side effects and costs. The aim of
this study was to review the effects of medicinal plants in the treatment of morphine addiction in experimental animals. In this
review article, by using keywords of morphine, withdrawal, and plants or herbal medicine in databases of indexing cites, desired
articles were obtained since 1994. Inclusion criteria for selecting articles were the articles related to application of medicinal
plants in decreasing symptoms resulting from morphine withdrawal were selected. Results of this study on experimental studies
have shown that medicinal plants such as Trachyspermum copticum L and Melissa officinalis decrease the symptoms of withdrawal
syndrome in a dose-dependent. Also, medicinal plants like Avena sativa, Hypericum perforatu, Passiflora incarnate, Valeriana officinalis,
Satureja hortensis L, and Mentha piperita can have effects on behavior, emotions, and other problems of addicts, decreasing
withdrawal symptoms. Results of this study showed that medicinal plants can be effective in controlling deprivation, decreasing
dependency creation, and possibly detoxification of opioid addicts.
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Addiction to opioids, including morphine, is one of the biggest
concerns of health system that imposes high economical costs
to society by afflicting many humans.1 Addiction is a recurring
chronic disease2 and the recurrence phenomenon is the most
important challenge in its treatment.3 It is estimated that 230
million people use illegal drugs at least once a year and 27million
people are addicted, andmore important, 12million people suffer
amoderate to severe disability attributable to illegal drug use, and
of these, more than 200 000 people die each year from drug use,
without thenumbers ondeath anddisability linked to alcoholuse.4
Addiction treatment is a planned action, aimed at achieving
abstinence or reducing substance abuse, reducing or preventing
the severity and frequency of relapse, and improving the adap-
tive functioning in abused subjects.5
Various kinds of addiction treatments have been developed,
including the use of a variety of pharmacological, psychologi-
cal, and social approaches. The duration of treatment lasts from
a few days to years depending on the subjects’ needs and the
availability of resources.2
Dropout or failure to complete treatment, is also common.
Dropout rates range from 24% to 50% in outpatient treatment,6
17% to 57% in inpatient treatment,7 32% to 67.7% in substitution
treatment,8 and from 18% to 44% in detoxification centers.9
Consumption of morphine and its combination with other
products is increasing in developing countries. Therefore,
proper treatment is needed.10 Continuous consumption of nar-
cotic drugs, including morphine, creates short-term and con-
stant changes in neuron performances sensitive to opioids
by stimulating adaptive mechanisms and affects the synaptic
plasticity mechanism of nervous structure. Constant changes
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created in brain, interaction between opioid drugs and synap-
tic plasticity in different areas of brain creates recurrence phe-
nomenon and causes addicts to remain vulnerable to relapse
after years of abstinence.11
The problem of addicts after stopping the use of morphine
is withdrawal syndrome. The main symptoms of the syn-
drome include physical symptoms like nausea, perspiration,
mydriasis, tachycardia, bellyache, articular and muscular
pains, reduced appetite, and mental symptoms like pain,
insomnia, anxiety, stress, depression, stimulation can be
stated.12 Various drugs are used to prevent or treat addic-
tion.13,14 However, experiences in recent decades have
shown that pharmaceutical drugs used to stop morphine use
have undesirable and harmful side effects and available
remedies have limited effectiveness.10 On the other hand,
medicinal plants have natural effective substances that can
affect body biochemical activities by imposing less side
effects and costs than pharmaceutical drugs.15 These medic-
inal plants have been shown to have promising effects on var-
ious diseases,16-21 in addition to having the ability to reduce
pain21 and addiction.22,23 The aim of this study was to review
effect of medicinal plants in morphine addiction treatment in
experimental rats.
Method
In this review article, by studying keywords of morphine, with-
drawal, and plants or herbal medicine, in databases of Google Scho-
lar, SID, PubMed, and some other indexing cites, or traditional
books, desired articles were obtained since 1994. Inclusion criteria
for selecting articles were determined as all original articles related
to the research topic. Then, the articles related to application of med-
icinal plants in decreasing symptoms resulting from morphine with-
drawal were selected.
Results
Trachyspermum copticum L
Trachyspermum copticum L is an annual and herbaceous plant
that grows in eastern areas of Iran, India, and Egypt. This
plant has antispasmodic effects.24 According to research con-
ducted in 2004 to study aqueous extract of this plant fruit in
the treatment of morphine addiction in male rats, Trachysper-
mum copticum L aqueous extract at dosages of 10%was effec-
tive in jumping, diarrhea, and preventing weight loss in
withdrawal syndrome symptoms.25 Other study performed
to determine the effects of Trachyspermum copticum L extract
injected in nucleus of paragigantocellularis on symptoms due
to morphine withdrawal syndrome in addict male rats, a
dosage-dependent decrease was shown in more qualitative
symptoms of withdrawal syndrome.26
Melissa officinalis
Melissa officinalis, which grows in different regions of Iran,24
has analgesic, antianxiety, sedative, antispasmodic, and hypno-
tic properties.27 According to a study performed in order to
investigate the effects of aqueous extract of Melissa officinalis
branches on symptoms resulting from morphine withdrawal in
male rats, the extract of Melissa officinalis with dosages of
10 and 25 mg/kg, dose dependently had significant reduction
on the number of jumps and defecate weight, 30 minutes before
naloxone injection, in comparison with control group.28
Melissa officinalis, through reduction of the activity of
serotonin and binding to g-aminobutyric acid A (GABA A)
receptor, reduces anxiety and in this way offsets the signs of
morphine withdrawal syndrome. It has been shown in a study
that intracerebral and intraperitoneal injection of GABA A,
agonist receptor decreased the naloxone-induced jumping in
morphine withdrawal syndrome in mice.29 It is likely that
some of the observed effects of Melissa officinalis extract are
induced by binding to the GABA A receptor.
Ferula persica L
Ferula persica L is another plant that grows in Shahmirzad
region in Semnan (Iran) and that has many food applications
and has been used extensively in traditional medicine.11 It has
different effects on nervous system, including analgesic, antic-
ramp, and antispasmodic activities on ileum contraction.29
Hydroalcoholic extract of aerial parts of Ferula persica L in
dosages of 50, 100, and 200 mg per kilogram of body weight
did not decrease the number of jumps resulted from naloxone
injection in addicted rats compared with the control group.
However, antispasmodic action of the plant on ileum causes
decrease in defecation in animals.30
Avena sativa
Avena sativa is a sedative and neurotonic and is used in tradi-
tional medicine to treat anxiety and insomnia, especially in
addicted subjects.15 The combination of the alcoholic extract
of Avena sativa, Hypericum perforatum, Passiflora incarnata,
and Lavandula officinalis (post and cotreated) have been
shown to significantly reduce morphine withdrawal symptoms.
Administration of the extract cocktail prior to naloxone
induced precipitation of withdrawal syndromes also reduced
the expression of syndrome signs.31
Lavandula officinalis
Lavandula officinalis has antispasmodic, antidepressant, and
sedative effects and reduces withdrawal symptoms.24,32
Hypericum perforatum
Hypericum perforatu, other than being an anti-addictive, is a
sedative and neurotonic plant. Hypericum perforatum is used
by many people, especially in Europe, as traditional drug.33
This plant is used to treat neurological diseases, especially
depression.34 In a study performed in 2009, inhibitive effect
of this plant on morphine withdrawal syndrome was investi-
gated. According to these results, behaviors of morphine with-
drawal syndrome, including jumping, standing, and bruxism in
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rats were significantly decreased when Hypericum perforatum
extract was used along with morphine consumption.35 Spasmo-
dic, analgesic, and antimigraine effects.
Hayprsyn in the plant inhibits the enzyme activity of mono-
amino oxidase and is used to treat depression. The most author-
itative scientific works such as basic and clinical books,
including Martindale and PDR (Physician’s Drug Reference),
approved36 the antidepressant effect of this plant. Hyperisin
in this plant inhibits the activity of monoamino oxidase, indu-
cing antidepressant activity.
Passiflora incarnate
Passiflora incarnate is a plant with antispasmodic and antian-
xiety effects.24,37 In a study by Kerachian et al,23 the effects of
4 plants—Hypericum perforatum, passiflora incarnate, Lavan-
dula officinalis, and Avena sativa (each 25%)—in decreasing
morphine withdrawal symptoms showed very good effect. Dur-
ing this study in both groups, either extract injection during
daily morphine injection for inhibitive effect of extract on
physical dependence creation, or posttreatment (extract
injected after dependence creation), withdrawal symptoms,
including behavior of standing on 2 feet, body stretching, jump-
ing, toe vibration, blink and ptosis were tested over a 30-minute
period. Findings of this test showed significant decrease in
more symptoms between control group and both groups of dur-
ing and posttreatment. This decrease was more evident in the
group that was given the extract along with morphine.15
Flavonoid krayzyn obtained from Passiflora incarnate
showed antioxidant and antianxiety activities. In vitro studies
have shown that krayzyn binds a type of GABA A receptor that
is called benzodiazepine receptor. Another study showed that
krayzyn is able to control withdrawal symptoms of morphine.38
Valeriana officinalis, Satureja hortensis L,
and Mentha piperita
Valeriana officinalis or Valerian has sedative, antispasmodic,
antianxiety, antipain, and hypnotic effects in human and
experimental animals.39 Satureja hortensis L is an herb of that
Labiatae family that shows antipain and antispasmodic proper-
ties.40 Mentha piperita is and aromatic plant that has antipain,
antispasmodic, and neurotonic properties.41,42 In the study by
Vafaei et al,43 effects of aqueous extract of Valeriana officina-
lis root, aerial parts of Satureja hortensis L, and hydroalcoholic
extract of aerial parts of Mentha piperita on symptoms due to
morphine withdrawal in male rat were investigated. According
to the results of this study, 25 mg of Valeriana officinalis
extract, 200 mg of Satureja hortensis L. and 50, 100, 200 and
500 mg/kg ofMentha piperita decreased significantly the num-
ber of jumping episodes due to naloxone injection to addicted
animals. Also, 5 and 100 mg of Valeriana officinalis, 25, 50,
100, and 200 mg of Satureja hortensis L, and 50, 100, 200, and
500 mg/kg of Mentha piperita significantly decreased defeca-
tion.42 Portulaca oleracea L is a herbaceous and meaty plant
that has antispasmodic and muscle relaxant properties.40
Portulaca Seed
Portulaca seeds at dosages of 25, 50, and 75 mg decreased num-
ber of jumps significantly 30 minutes before naloxone injec-
tion to addicted animal and caused significant decrease in
defecation.43
The results of a study indicated that Portulacea extract could
decrease morphine dependence in mice. Both extracts of Portu-
laca reduced the jumping episodes dose-dependently. The max-
imum effect was observed at doses of 0.28 and 1.4 g/kg for the
aqueous and ethanolic extracts, respectively. The extracts and
clonidine also decreased the total activity in locomotion test.31
Benincasa hispida
Fresh extract of Benincasa hispida has useful effects in neuro-
logical diseases, including spasm and nociception in experi-
mental animals.44 According to a study performed in 2000,
edible injection of Benincasa hispida fresh extract caused sig-
nificant decrease in number of jumps and amount of defecation
in morphine-dependent rats.45
Areca catechu
In one study, intraperitoneal injection of 125 and 175 mg/kg
of Areca catechu dichloromethane extract dose-dependently
delayed beginning of jumping, and decreased amount of
urination and defecation in naloxone-induced withdrawal in
morphine-addicted rats.46
Papaver rhoeas L
Papaver rhoeas L is used as an analgesic, anti-inflammation,
sedative, and narcotic and also in the treatment of an exten-
sive range of diseases like diarrhea and sleeping disorders.24
In a study in rat, the hydroalcoholic extract effect of Papaver
rhoeas L on morphine dependence and development was
studied. Injection of this extract, 30 minutes before naloxone
injection and in dosages of 25, 50, and 100 mg/kg decreased
number of jumping and diarrheal dose-dependently. This is
while extract injection 30 minutes before morphine injection
and in mentioned dosages, increased the number of jumping
and diarrhea.47
Rosmarinus officianalis
Rosmarinus officianalis is a plant that has many traditional uses
worldwide.48 In one study, intraperitoneal injection of 2.4
and 1.68 g/kg of Rosmarinus officianalis aqueous extract and
0.96 g/kg of alcoholic extract caused decrease in number of
jumps in morphine-dependent rats.49
Crocus sativus
Pappus of Crocus sativus having golden color and pleasant
flavor is a widely used plant that has antidepressant and antian-
xiety properties.50 Alcohol and aqueous extracts of saffron
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dose-dependently decreased the number of jumps in morphine-
addicted rats.51
Saffron extract contains several constituents, including safra-
nal, crocin, and crocetin, which may affect several physical and
psychological signs of morphine dependence. Administration of
saffron extract was shown to reduce morphine sensitization and
morphine tolerance. Also aqueous and ethanolic extracts could
have interaction with the opioid system to reduce withdrawal
syndrome in morphine dependent animals.52
Withania somnifera
Withania somnifera is commonly used in Eastern countries,
Africa, and India to treat diseases, including neurological dis-
eases.53 According to a study in 2009 the use of this plant with
morphine in male rats decreased symptoms resulting from mor-
phine withdraw.54
Delphinium denudatum
Delphinium denudatum plant has antispasmodic property in
rats55 and has extensive range of antistress activities on differ-
ent stressors.56 In one study, effect of methanolic extract of
Delphinium denudatum on inhibiting morphine withdrawal
symptoms in 3 groups of rats that were pretreated, posttreated,
or simultaneously treated with morphine was investigated.
According to results of this study, Delphinium denudatum
extract in all 3 groups of animals decreased the symptoms
resulting from morphine withdrawal. The maximum effect of
the extract in decreasing symptoms was observed in posttreat-
ment group with 700 mg/kg dosage, in simultaneously treated
with 700 mg/kg dosage, and in pretreatment with 350 mg/kg.57
The dosages of Delphinium denudatum given in this study
(especially 700 mg/kg) are large. How would these doses be
adjusted and administered in humans and the safety of plant
in these doses is not clear and should be established.
Peganum harmala
Harmelin available in Peganum harmala is a monoamine oxi-
dase inhibitor and can eliminate and sedate withdrawal symp-
toms. Maximum effectiveness has been attributed to berberine,
which is one of the alkaloids available in Berberies plant.58
Berberis vulgaris L in low dosages has antianxiety properties.59
Discussion
With regard to the fact that thymol is the substance most widely
available in Trachyspermum ammi plant, possibly its therapeu-
tic property is related to this substance. This plant—by affect-
ing serotonergic, cholinergic, GABA A, and 2a adrenergic
systems—can have an effect on decreasing symptoms due to
morphine withdrawal.25 Also, nucleus paragigantocellularis is
one of the most important areas related to addiction. Injection
of Trachyspermum ammi extract in this nucleolus, through
decreasing the amounts of aspartate and glutamate, decreases
qualitative symptoms of withdrawal syndrome.26 The ability
to express anxiety effects in stressful conditions in morphine-
dependent rats may accrue more rapid without imposing any
effect on their motor activity.
Anxiety is considered as one of the strong factors in ten-
dency to receive drug.60 Anxiety can play a crucial role in pre-
ferential increasing of morphine dependence in rats in the
conditioned place preference test and interest in morphine can
be decreased in dependent animals when anxiety is treated.
So, with regard to antianxiety and sedative effects of Melissa
officinalis extract, possibly effects of preferential increase in
the conditioned place preference test is decreased and so can
regulate morphine withdrawal symptoms. Citronella available
in this plant reinforces sleeping and decreases muscle tone.61
Of other effective factors in decreasing symptoms due to mor-
phine withdrawal syndrome in Melissa officinalis, the acetyl-
cholinesterase activity and binding to GABA A receptor can
be quoted.28
Terpenoids and menoperin available in the Ferula persica L
plant possibly causes sedative and hypnotic activity of this
plant. This plant contains antispasmodic compounds on smooth
muscles and lacks compounds that affect decreasing number
of jumps. So, possibly the hydroalcoholic extract of Ferula
persica L has not effect on symptoms resulted from morphine
withdraw, and only has hypnotic effects and is effective in
decreasing diarrhea dose-dependently.30 Benzoflavone avail-
able in Passiflora caerulea causes synaptic inhabitation by
affecting one of the GABA receptors and is effective in
decreasing pain and anxiety by providing significant decrease
in activity of central nervous system. Furthermore, this com-
pound prevents weight decrease. Linalool available in Lavan-
dula also has sedative and analgesic effects.62 Hypericum
perforatum inhibits P450 cytochrome isoenzymes, and so this
plant can be used to increase half-life of common drugs used
in morphine withdrawal. Of other mechanisms effective in
inhibition of symptoms by Hypericum perforatum is the inhibi-
tion calcium binding to voltage-dependent calcium channels in
presynaptic membrane that causes induction of antispasmodic
effects of this plant. Different studies have shown that seeds
of Avena sativawithout harmful effects can significantly sedate
the nervous system. As mentioned before, one of the main and
problematic symptoms of withdrawal syndrome is anxiety that
Avena sativa, Hypericum perforatum, and Passiflora caerulea
plants are effective in decreasing by complementing each oth-
er’s effects.29 Valerian and valeinic acid of Valeriana officina-
lis derivatives imitate GABA A activity and increase release of
GABA intermediate and decrease its reuptake. So, antispasmo-
dic, analgesic, antianxiety, and hypnotic effects of Valeriana
officinalis are justifiable. Also the mentioned plant creates
antispasmodic effect by influencing calcium channels or affect-
ing on digestive system directly. Carvacrol and flavonoid in
Satureja causes analgesic effects. Mentha piperita decreases
pain by affecting kappa-opioid receptors and inhibiting pain
signal transfer.
Portulaca is rich in potassium ion and contains flavonoids,
mosulgae, and pectin. These compounds act as muscle relaxants
and decrease diarrhea. Also, this plant, by having antianxiety
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effect63 and affecting internal opioid receptors, causes the prefer-
ential increase in the conditioned place preference test; hence, it
decreases and regulates symptoms of morphine withdrawal
syndrome.26 Compounds in honeydew that affect withdrawal
syndrome are possibly triterpene, sterol, and glycoside.45 As was
mentioned in Results section, Delphinium denudatum plant has
extensive antistress activity and limits morphine physical depen-
dence but its performance mechanism is not yet determined.57
Possibly Papaver rhoeas L causes limitation in symptoms result-
ing due tomorphine withdrawal by anticholinergic and antidopa-
minergic activity.47 Rosemary contains alkaloids, saponins,
tannins, and flavonoids that impart analgesic properties. Possi-
bly, this plant decreases morphine withdrawal symptoms
through GABA system.49 Hypericum perforatum decreases
temptation by benefiting opioid antagonists and decreases symp-
toms resulting from morphine withdrawal in addition to its anti-
depression properties.64
Saffron contains sedative and antianxiety compounds that
cause increase in sleep duration and decrease in withdrawal
symptoms by its hexobarbital. Possibly compounds like flavo-
noids and crocin pigment are effective in decreasing these
symptoms.51 Also dichloromethane available in Areca catechu
extract inhibits monoamine oxidase enzyme and increases
bioavailability and neurological transfer of serotonergic and
noraderenergenic system.46 Which system is involved in reduc-
tion of withdrawal symptoms is not clear. Pretreatment with
Withania somnifera extract also causes protection of structural
changes (decreasing density of dendritic thorns of nucleus
accumbens).42 Ginseng decreases anxiety and depression in
withdrawal syndrome through corticotrophin-releasing factor
system, and hypothalamic neuropeptide Y.65
It should be noted that withdrawal syndrome is accompa-
nied with sever increase in oxidative stress.66 Most of medic-
inal plants possess antioxidant activity,67-70 thanks to
polyphenolic compounds such as flavonoids, flavonols, and
anthocyanins.70-73 Oxidative stress is involved in several
difficult-to-cure diseases such as diabetes,74-76 atherosclero-
sis,77,78 cardiovascular diseases,79,80 cancer,81,82 Alzheimer’s
disease,83 gastrointestinal disorders,84,85 and infectious86,87
diseases. Medicinal plants with antioxidant activities have
been able to counteract the development of these complica-
tions.88-102 Therefore, the plants effective in withdrawal syn-
drome should counteract, at least in part, oxidative stress
induced through withdrawal syndrome, thereby reducing its
symptoms. The antioxidants usually scavenge the free radi-
cals that cause oxidative stress.102-111
Conclusion
Results of this study showed that medicinal plants can be effec-
tive in decreasing dependence, controlling withdrawal, and
possibly detoxication in rats. The use of combined extracts of
several plants that have antianxiety, antispasmodic, analgesic,
and antidepression effects with suitable dosage in morphine
withdrawal should be examined in experimental models.
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